Express Pharma - Page 2210 of 2240 - Express Pharma

Government caps margins on cancer medicines at 30%, targets ₹2,500 Cr annual savings

Lupin receives USFDA approval for Phytonadione Injectable Emulsion

Why industry-academia collaboration will shape India’s next R&D chapter

Wyatt Technology launches DynaPro Plate Reader II

Vetter expands its capacities and services for prefilled syringes

ArisGlobal launches new version of medical information management system

Stem cells in predictive toxicology

New second-line drug for type II diabetes results in less hypoglycaemia: The Lancet

Imminent patent expiry of key blockbusterdDrugs to benefit generics manufacturers: Frost & Sullivan

Mylan confirms first-to-file patent challenge relating to Pristique tablets

Drug pricing norms: Cost or MRP based?

Venus Remedies: Reinventing R&D

Regulatory woes of pharma SMEs (Part I)